[go: up one dir, main page]

SV1994000071A - Procedimiento de una etapa para la fabricacion de derivados de acido 3-quinoloncarboxilico, ref. le a 29 572-sv. - Google Patents

Procedimiento de una etapa para la fabricacion de derivados de acido 3-quinoloncarboxilico, ref. le a 29 572-sv.

Info

Publication number
SV1994000071A
SV1994000071A SV1994000071A SV1994000071A SV1994000071A SV 1994000071 A SV1994000071 A SV 1994000071A SV 1994000071 A SV1994000071 A SV 1994000071A SV 1994000071 A SV1994000071 A SV 1994000071A SV 1994000071 A SV1994000071 A SV 1994000071A
Authority
SV
El Salvador
Prior art keywords
chinoloncarboxylic
manufacture
acid derivatives
procedure
ref
Prior art date
Application number
SV1994000071A
Other languages
English (en)
Inventor
Paul Naab
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SV1994000071A publication Critical patent/SV1994000071A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Photolithography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

UN PROCEDIMIENTO DE UNA SOLA ETAPA PARA LA FABRICACION DE DERIVADOS DE ACIDO 3-QUINOLONCARBOXILICO SUBSTITUIDO CON 7-HETEROCICLILO, TIENEN UNA ACTIVIDAD ANTIMICROBIANA FUERTE. A ELLOS PERTENECEN SUBSTANCIAS ACTIVAS COMO, POR EJEMPLO OFLOXACINA, CIPROFLOXACINA O ENROFLOXACINA.
SV1994000071A 1993-12-10 1994-12-08 Procedimiento de una etapa para la fabricacion de derivados de acido 3-quinoloncarboxilico, ref. le a 29 572-sv. SV1994000071A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4342186A DE4342186A1 (de) 1993-12-10 1993-12-10 Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten

Publications (1)

Publication Number Publication Date
SV1994000071A true SV1994000071A (es) 1995-07-29

Family

ID=6504693

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1994000071A SV1994000071A (es) 1993-12-10 1994-12-08 Procedimiento de una etapa para la fabricacion de derivados de acido 3-quinoloncarboxilico, ref. le a 29 572-sv.

Country Status (35)

Country Link
US (1) US5639886A (es)
EP (1) EP0657448B1 (es)
JP (1) JP3963490B2 (es)
KR (1) KR950018008A (es)
CN (1) CN1109877A (es)
AT (1) ATE163645T1 (es)
AU (1) AU693818B2 (es)
BG (1) BG61947B1 (es)
CA (1) CA2137523C (es)
CO (1) CO4180607A1 (es)
CZ (1) CZ288078B6 (es)
DE (2) DE4342186A1 (es)
DK (1) DK0657448T3 (es)
EE (1) EE03215B1 (es)
ES (1) ES2113040T3 (es)
FI (1) FI945776L (es)
GR (1) GR3026383T3 (es)
HR (1) HRP940950B1 (es)
HU (1) HU220597B1 (es)
IL (1) IL111921A (es)
LV (1) LV11470B (es)
MY (1) MY113302A (es)
NO (1) NO307180B1 (es)
NZ (1) NZ270086A (es)
PE (1) PE33795A1 (es)
PL (1) PL180022B1 (es)
RO (1) RO113345B1 (es)
RU (1) RU2138483C1 (es)
SI (1) SI0657448T1 (es)
SK (1) SK279950B6 (es)
SV (1) SV1994000071A (es)
TW (1) TW401412B (es)
UA (1) UA41323C2 (es)
YU (1) YU48865B (es)
ZA (1) ZA949830B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826050A1 (de) * 1998-06-12 1999-12-16 Bayer Ag Verfahren zur Herstellung von Chinolon- und Naphthyridoncarbonsäuren und deren Ester
HK1048119A1 (en) * 2000-02-25 2003-03-21 Daiichi Pharmaceutical Co., Ltd. Process for producing quinolonecarboxylic acids and intermediates thereof
US6608078B2 (en) 2000-05-08 2003-08-19 Wockhardt Limited Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment
DE10026903A1 (de) * 2000-06-03 2002-01-10 Cpc Cellular Process Chemistry Verfahren zur Herstellung von Chinolon-3-carbonsäuren
US7098219B2 (en) 2000-08-01 2006-08-29 Wockhart Limited Inhibitors of cellular efflux pumps of microbes
US6878713B2 (en) 2001-04-25 2005-04-12 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
WO2003099815A1 (en) * 2002-05-28 2003-12-04 Wockhardt Limited Crystalline fluoroquinolone arginine salt form
KR100519158B1 (ko) * 2002-12-21 2005-10-06 주식회사유한양행 퀴놀론 카르복실레이트 유도체의 제조방법
CA2537066C (en) 2003-09-04 2011-05-24 Wockhardt Limited Benzoquinolizine-2-carboxylic acid arginine salt tetrahydrate
WO2005026145A2 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
CN100412075C (zh) * 2004-06-22 2008-08-20 浙江医药股份有限公司新昌制药厂 左旋氧氟沙星和氧氟沙星的制备方法
AU2007320997B2 (en) 2006-11-13 2012-11-08 Cipla Limited Process for the synthesis of moxifloxacin hydrochloride
EP1992626A1 (en) * 2007-05-10 2008-11-19 Sandoz AG Process for the preparation of moxifloxacin hydrochloride
FR2916446B1 (fr) * 2007-05-24 2009-08-21 Biocodex Sa Nouveau procede de synthese de fluoroquinolones
EP2083010A1 (en) 2008-01-08 2009-07-29 Chemo Ibérica, S.A. Polymorphic Forms of Moxifloxacin hydrochloride and processes for preparation thereof
CN101781299B (zh) * 2010-01-13 2012-06-27 杭州师范大学 一种喹诺酮类药物关键中间体的一锅法合成方法
IT1398952B1 (it) 2010-03-19 2013-03-28 F S I Fabbrica Italiana Sint Processo di preparazione della moxifloxacina e suoi sali
CN102675306A (zh) * 2011-03-17 2012-09-19 苏州中科天马肽工程中心有限公司 一种莫西沙星或其盐的制备方法
CN102267994B (zh) * 2011-06-17 2013-01-30 江苏正大丰海制药有限公司 一种盐酸莫西沙星已知杂质的制备方法
WO2013157018A1 (en) 2012-04-18 2013-10-24 Indian Institute Of Technology Madras A process for the preparation of the core structure in quinolone and napthyridone class of antibiotics
WO2014087292A1 (en) 2012-12-04 2014-06-12 Mankind Research Centre An improved process for the preparation of moxifloxacin hydrochloride
UA106556C2 (uk) 2013-05-13 2014-09-10 Наталья Николаевна Деркач СПОСІБ ОДЕРЖАННЯ (1-ЦИКЛОПРОПІЛ-6-ФТОР-1,4-ДИГІДРО-8-МЕТОКСІ-7-[(4aS,7aS)-ОКТАГІДРО-6Н-ПІРОЛО[3,4-b]-4-ОКСО-3-ХІНОЛІНКАРБОНОВОЇ КИСЛОТИ
CN111032622A (zh) * 2017-06-12 2020-04-17 弗吉尼亚联邦大学 流线型合成氟喹诺酮类
CN115385856A (zh) * 2022-09-05 2022-11-25 常州大学 一锅法合成诺氟沙星中间体的方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420743A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-6,8-dihalogen-1,4-dihydro-4-oxo-3-chinolincarbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US5468861A (en) * 1984-06-04 1995-11-21 Bayer Aktiengesellschaft 8-chloro-1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid and alkyl esters thereof
JPS62215572A (ja) * 1986-03-17 1987-09-22 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体
JPS63179856A (ja) 1987-01-21 1988-07-23 Kyorin Pharmaceut Co Ltd キノロンカルボン酸誘導体の製造方法並びにその中間体
DE3724466A1 (de) 1987-07-24 1989-02-02 Bayer Ag Verfahren zur herstellung von chinoloncarbonsaeuren
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
WO1989005643A1 (en) * 1987-12-18 1989-06-29 Pfizer Inc. Heterocyclic-substituted quinoline-carboxylic acids
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
DE4208792A1 (de) 1992-03-19 1993-09-23 Bayer Ag Enantiomerenreine chinolincarbonsaeure-derivate
TW209865B (es) * 1992-01-10 1993-07-21 Bayer Ag
DE4208789A1 (de) 1992-03-19 1993-09-23 Bayer Ag Enantiomerenreine chinolincarbonsaeure-derivate
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
AU679961B2 (en) * 1993-08-13 1997-07-17 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives

Also Published As

Publication number Publication date
US5639886A (en) 1997-06-17
PE33795A1 (es) 1995-12-15
NO944786D0 (no) 1994-12-09
FI945776A7 (fi) 1995-06-11
SK279950B6 (sk) 1999-06-11
GR3026383T3 (en) 1998-06-30
CA2137523A1 (en) 1995-06-11
CA2137523C (en) 2007-05-22
LV11470A (lv) 1996-08-20
FI945776L (fi) 1995-06-11
CO4180607A1 (es) 1995-06-07
YU71694A (sh) 1996-10-18
CZ310594A3 (en) 1995-09-13
HU9403553D0 (en) 1995-02-28
JPH07196621A (ja) 1995-08-01
KR950018008A (ko) 1995-07-22
FI945776A0 (fi) 1994-12-08
CN1109877A (zh) 1995-10-11
DE59405376D1 (de) 1998-04-09
NZ270086A (en) 1996-02-27
RO113345B1 (ro) 1998-06-30
YU48865B (sh) 2002-08-12
BG61947B1 (bg) 1998-10-30
TW401412B (en) 2000-08-11
RU94043645A (ru) 1996-10-27
JP3963490B2 (ja) 2007-08-22
IL111921A (en) 1999-07-14
CZ288078B6 (cs) 2001-04-11
AU8024494A (en) 1995-06-15
HRP940950B1 (en) 1998-12-31
HU220597B1 (hu) 2002-03-28
ZA949830B (en) 1995-08-22
HRP940950A2 (en) 1997-02-28
EE03215B1 (et) 1999-08-16
PL180022B1 (pl) 2000-12-29
ES2113040T3 (es) 1998-04-16
AU693818B2 (en) 1998-07-09
BG99248A (en) 1995-09-29
IL111921A0 (en) 1995-03-15
DE4342186A1 (de) 1995-06-14
MY113302A (en) 2002-01-31
NO944786L (no) 1995-06-12
UA41323C2 (uk) 2001-09-17
RU2138483C1 (ru) 1999-09-27
ATE163645T1 (de) 1998-03-15
EP0657448B1 (de) 1998-03-04
PL306198A1 (en) 1995-06-12
EP0657448A1 (de) 1995-06-14
SK151494A3 (en) 1995-07-11
NO307180B1 (no) 2000-02-21
SI0657448T1 (en) 1998-06-30
LV11470B (en) 1996-12-20
DK0657448T3 (da) 1998-12-21
HUT72058A (en) 1996-03-28

Similar Documents

Publication Publication Date Title
SV1994000071A (es) Procedimiento de una etapa para la fabricacion de derivados de acido 3-quinoloncarboxilico, ref. le a 29 572-sv.
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
UA26097A1 (uk) Триазиhові похідhі, що мають гербіцидhу активhість, спосіб їх одержаhhя та гербіцидhа композиція hа їх осhові
IL56369A (en) Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
UA19303A (uk) Спосіб одержаhhя похідhих 2-аhіліhопіримідиhу
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2181682T3 (es) Utilizacion de licopeno para reducir la actividad de las celulas, en particular celulas cancerosas y preparaciones farmaceuticas.
IT8123602A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
PT89534A (pt) Processo para a preparacao de composicoes farmaceuticas anticoagulantes contendo como ingrediente activo proteina c ou proteina c activada combinada com heparina
AR240225A1 (es) Composicion insecticida que comprende mas de un compuesto activo.
CO5001019A1 (es) Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales
FI911863A7 (fi) Metyleenidifosfonihappoyhdiste ja tulehdusta estävä aine, joka sisältä ä tätä yhdistettä tehokomponenttina
DE19475001I2 (de) Anthelminthische Wirkstoffkombinationen.
ES2193246T3 (es) Cefalosporinas antibacterianas.
IT8123940A0 (it) Derivati della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che licontengono come principio attivo.
IT8123603A0 (it) Sali stabili della s-adenosilmetionina, processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo.
ES2090083T3 (es) Derivados de cefalosporina, procedimiento para su preparacion y composicion antimicrobiana que contiene estos derivados.
BG45552A3 (bg) Метод за получаване на 2-фенил-хексахидро-1,2,4- триазин-3,5-диони
GR1001511B (el) Στεροειδείς συν?έσεις.
ES2173871T3 (es) Tratamiento de condiciones neurologicas por un compuesto inhibidor de la interleukina-1.
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
IT8522359A0 (it) Composizioni farmaceutiche che li derivati di vitamina d,contengono e loro precursori.

Legal Events

Date Code Title Description
FG Grant
FD Lapse